Eversept Partners, LP
- SEC CIK
- 0001697013
- 最新申報
- 2026/8/14
2024 年第 1 季持倉
持倉截至 2024/3/31，2024/5/15 申報。只含多頭部位，變化是跟 2023 年第 4 季比股數。
- 持股檔數
- 68
- 較 2023 年第 4 季 +13
- 總值
- $13.4 億
- 較 2023 年第 4 季 +$3.18 億 (+31.2%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| NTRANatera, Inc. | COM | 1,778,051 | $1.63 億 | 12.2% | −473,537−21.0% | 減碼 | 歷史 |
| GSKGSK plc | ADR | 3,771,994 | $1.62 億 | 12.1% | +799,040+26.9% | 加碼 | 歷史 |
| INSPInspire Medical Systems, Inc. | COM | 420,699 | $9,036 萬 | 6.8% | +69,583+19.8% | 加碼 | 歷史 |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 6,025,169 | $8,502 萬 | 6.4% | −129,185−2.1% | 減碼 | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 1,823,781 | $7,864 萬 | 5.9% | −91,049−4.8% | 減碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 3,133,113 | $7,457 萬 | 5.6% | −250,131−7.4% | 減碼 | 歷史 |
| UTHRUnited Therapeutics Corp | COM | 251,135 | $5,769 萬 | 4.3% | +4,901+2.0% | 加碼 | 歷史 |
| RVTYRevvity, Inc. | COM | 483,160 | $5,073 萬 | 3.8% | +300,101+163.9% | 加碼 | 歷史 |
| TECHBIO-TECHNE Corp | COM | 607,687 | $4,278 萬 | 3.2% | +142,380+30.6% | 加碼 | 歷史 |
| HCAHCA Healthcare, Inc. | COM | 103,821 | $3,463 萬 | 2.6% | −10,984−9.6% | 減碼 | 歷史 |
| HQYHealthequity, Inc. | COM | 421,345 | $3,439 萬 | 2.6% | −73,574−14.9% | 減碼 | 歷史 |
| PFEPfizer Inc | Stock | 1,102,042 | $3,058 萬 | 2.3% | +1,102,042 | 新進 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 711,115 | $2,985 萬 | 2.2% | −42,992−5.7% | 減碼 | 歷史 |
| CYHCommunity Health Systems Inc | COM | 7,980,641 | $2,793 萬 | 2.1% | +749,515+10.4% | 加碼 | 歷史 |
| SWAVShockwave Medical, Inc. | COM | 80,555 | $2,623 萬 | 2.0% | +4,733+6.2% | 加碼 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 54,518 | $2,146 萬 | 1.6% | −31,314−36.5% | 減碼 | 歷史 |
| THCTenet Healthcare Corp | COM NEW | 175,631 | $1,846 萬 | 1.4% | −11,634−6.2% | 減碼 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 376,438 | $1,632 萬 | 1.2% | +51,784+16.0% | 加碼 | 歷史 |
| VTRSViatris Inc | Stock | 1,316,469 | $1,572 萬 | 1.2% | +1,316,469 | 新進 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 197,331 | $1,348 萬 | 1.0% | −36,508−15.6% | 減碼 | 歷史 |
| HUMHumana Inc | Stock | 35,532 | $1,232 萬 | 0.9% | +33,618+1,756.4% | 加碼 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 411,478 | $1,190 萬 | 0.9% | −126,596−23.5% | 減碼 | 歷史 |
| Taro Pharmaceutical Inds LtdM8737E108 | SHS | 263,541 | $1,116 萬 | 0.8% | +7,553+3.0% | 加碼 | – |
| MNKDMannkind Corp | COM NEW | 2,391,128 | $1,083 萬 | 0.8% | +2,391,128 | 新進 | 歷史 |
| DHRDanaher Corp | Stock | 40,855 | $1,020 萬 | 0.8% | −186−0.5% | 減碼 | 歷史 |
| LLYEli Lilly & Co | Stock | 12,877 | $1,002 萬 | 0.7% | +12,877 | 新進 | 歷史 |
| ZIMVZimVie Inc. | Stock | 564,498 | $930.9 萬 | 0.7% | +18,054+3.3% | 加碼 | 歷史 |
| GHGuardant Health, Inc. | COM | 449,586 | $927.5 萬 | 0.7% | +449,586 | 新進 | 歷史 |
| BKDBrookdale Senior Living Inc. | COM | 1,318,765 | $871.7 萬 | 0.7% | +1,318,765 | 新進 | 歷史 |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 353,965 | $837.1 萬 | 0.6% | −20,439−5.5% | 減碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 255,526 | $825.6 萬 | 0.6% | +141,733+124.6% | 加碼 | 歷史 |
| NVONovo Nordisk A S | ADR | 62,344 | $800.5 萬 | 0.6% | +62,344 | 新進 | 歷史 |
| KPTIKaryopharm Therapeutics Inc. | COM | 5,016,320 | $757.5 萬 | 0.6% | +5,016,320 | 新進 | 歷史 |
| PBYIPuma Biotechnology, Inc. | COM | 1,426,497 | $756.0 萬 | 0.6% | −268,524−15.8% | 減碼 | 歷史 |
| ELVElevance Health, Inc. | Stock | 14,393 | $746.3 萬 | 0.6% | −701−4.6% | 減碼 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 955,618 | $736.8 萬 | 0.6% | +955,618 | 新進 | 歷史 |
| CNCCentene Corp | Stock | 92,786 | $728.2 萬 | 0.5% | −4,412−4.5% | 減碼 | 歷史 |
| BCRXBiocryst Pharmaceuticals Inc | COM | 1,432,427 | $727.7 萬 | 0.5% | −96,620−6.3% | 減碼 | 歷史 |
| GOSSGossamer Bio, Inc. | COM | 5,994,472 | $707.3 萬 | 0.5% | −438,243−6.8% | 減碼 | 歷史 |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 2,325,591 | $667.4 萬 | 0.5% | −1,455,123−38.5% | 減碼 | 歷史 |
| TSVT2seventy bio, Inc. | COMMON STOCK | 1,177,678 | $630.1 萬 | 0.5% | +38,567+3.4% | 加碼 | 歷史 |
| STROSutro Biopharma, Inc. | COM | 1,091,419 | $616.7 萬 | 0.5% | +34,958+3.3% | 加碼 | 歷史 |
| LQDALiquidia Corp | COM NEW | 396,187 | $584.4 萬 | 0.4% | −292,739−42.5% | 減碼 | 歷史 |
| NVRONevro Corp | COM | 389,663 | $562.7 萬 | 0.4% | +389,663 | 新進 | 歷史 |
| AMRNAmarin Corp PLC | SPONS ADR NEW | 6,212,748 | $553.4 萬 | 0.4% | +117,243+1.9% | 加碼 | 歷史 |
| MRUSMerus N.V. | COM | 119,482 | $538.0 萬 | 0.4% | +3,756+3.2% | 加碼 | 歷史 |
| ICLRIcon PLC | COM | 15,347 | $515.6 萬 | 0.4% | −70−0.5% | 減碼 | 歷史 |
| WATWaters Corp | COM | 13,628 | $469.1 萬 | 0.4% | −14,091−50.8% | 減碼 | 歷史 |
| STOKStoke Therapeutics, Inc. | COM | 290,000 | $391.5 萬 | 0.3% | +290,000 | 新進 | 歷史 |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM NEW | 88,934 | $349.0 萬 | 0.3% | +88,934 | 新進 | 歷史 |
| KRYSKrystal Biotech, Inc. | COM | 18,557 | $330.2 萬 | 0.2% | −62,241−77.0% | 減碼 | 歷史 |
| ALECAlector, Inc. | COM | 536,171 | $322.8 萬 | 0.2% | +536,171 | 新進 | 歷史 |
| AVTRAvantor, Inc. | COM | 125,394 | $320.6 萬 | 0.2% | −570−0.5% | 減碼 | 歷史 |
| IQVIQVIA Holdings Inc. | Stock | 12,178 | $308.0 萬 | 0.2% | −85−0.7% | 減碼 | 歷史 |
| Morphosys AG617760202 | SPONSORED ADS | 165,924 | $301.0 萬 | 0.2% | +165,924 | 新進 | – |
| VRDNViridian Therapeutics, Inc. | COM | 142,075 | $248.8 萬 | 0.2% | +4,732+3.4% | 加碼 | 歷史 |
| MOHMolina Healthcare, Inc. | COM | 5,828 | $239.4 萬 | 0.2% | −289−4.7% | 減碼 | 歷史 |
| XOMAXOMA Royalty Corp | COM NEW | 97,065 | $233.4 萬 | 0.2% | +3,338+3.6% | 加碼 | 歷史 |
| IFRXInflaRx N.V. | COM | 1,305,140 | $201.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 22,818 | $187.1 萬 | 0.1% | +22,818 | 新進 | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 283,034 | $185.7 萬 | 0.1% | +283,034 | 新進 | 歷史 |
| JBIOJade Biosciences, Inc. | COM | 54,150 | $160.1 萬 | 0.1% | +3,908+7.8% | 加碼 | 歷史 |
| Curevac N VN2451R105 | COM | 515,691 | $156.3 萬 | 0.1% | +18,779+3.8% | 加碼 | – |
| RGENRepligen Corp | COM | 8,237 | $151.5 萬 | 0.1% | −1,747−17.5% | 減碼 | 歷史 |
| MCRBSeres Therapeutics, Inc. | COM | 1,388,944 | $107.5 萬 | 0.1% | −364,594−20.8% | 減碼 | 歷史 |
| Affimed N VN01045207 | ORDINARY SHS NEW | 166,460 | $88.2 萬 | 0.1% | +166,460 | 新進 | – |
| VINCVincerx Pharma, Inc. | COM NEW | 79,588 | $40.3 萬 | <0.1% | +79,588 | 新進 | 歷史 |
| ACIUAC Immune SA | SHS | 124,589 | $36.9 萬 | <0.1% | 00.0% | 不變 | 歷史 |
選擇權（2 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| Invesco QQQ Trust Series I46090E103 | ETF | $1.45 億 | – |
| SPYSPDR S&P 500 ETF Trust | ETF | $1,585 萬 | – |
2023 年第 4 季之後清倉（5 檔）
2023 年第 4 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2023 年第 4 季股數 | 2023 年第 4 季市值 | 2023 年第 4 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| IMGNImmunoGen, Inc. | COM | 748,950 | $2,221 萬 | 2.2% | 歷史 |
| ILMNIllumina, Inc. | COM | 86,614 | $1,206 萬 | 1.2% | 歷史 |
| AAgilent Technologies, Inc. | COM | 37,854 | $526.3 萬 | 0.5% | 歷史 |
| BHVNBiohaven Ltd. | COM | 66,898 | $286.3 萬 | 0.3% | 歷史 |
| Affimed N VN01045108 | COM | 1,676,684 | $104.8 萬 | 0.1% | – |